Constipation in Children
Clinical Snapshot
Constipation in children is extremely common, and in the large majority of cases it is functional — meaning it cannot be attributed to a structural, neurologic, or other medical cause. The dominant mechanism is a self-perpetuating cycle of stool withholding: a child who has passed one hard or painful bowel movement learns to voluntarily contract the pelvic floor and gluteal muscles to avoid passing the next one, which allows more water to be reabsorbed from the retained stool in the rectum, making it progressively harder and more painful to pass. This cycle — not a primary transit or pelvic-floor disorder, which dominate the adult framework — is the core of pediatric functional constipation. Withholding behaviour is frequently mistaken by caregivers for straining to have a bowel movement, and overflow leakage around a large retained fecal mass is frequently mistaken for diarrhea or a separate soiling problem rather than recognized as a manifestation of the underlying constipation. Diagnosis is clinical, using the age-stratified Rome IV criteria, and treatment follows a two-phase paradigm — disimpaction (clean-out) of retained stool, followed by a maintenance phase measured in months rather than weeks — built around weight-based polyethylene glycol 3350 dosing that differs structurally at every step from adult dosing.[1]
Recognize the Condition
Withholding behaviour — the presentation most often missed or misread
After an episode of painful defecation, a child will often actively avoid having another bowel movement rather than simply having "trouble" passing stool. Caregivers frequently describe this withholding as straining or as the child "trying" to go, when the behaviour is actually the opposite — an active attempt to retain stool.
- Stiffening the legs and body, standing on the toes, or arching the back.
- Rocking, crossing the legs, or clenching the buttocks together.
- Hiding in a corner or behind furniture at the moment of urge.
- Going red in the face, appearing distressed, or crying at the moment of urge — easily mistaken for a child straining to pass stool rather than actively withholding it.
Overflow fecal incontinence (encopresis) — a symptom of constipation, not a separate diagnosis
Once the rectum becomes distended enough by retained hard stool, looser stool from higher in the colon can leak around the impacted mass. Caregivers and even clinicians can mistake this frequent, small-volume, sometimes watery leakage for diarrhea, and fail to connect it to an underlying large fecal mass. Recognizing overflow incontinence as a presentation of constipation — not a competing diagnosis — changes the management from anti-diarrheal measures to disimpaction. Males are more likely than females to develop this pattern, and it becomes easier to recognize once a child is no longer in diapers.
Abdominal pain as the presenting complaint
Constipation is one of the most common causes of abdominal pain in children, and pain — rather than a caregiver-reported change in stool pattern — is often the chief complaint that brings a family to care, with the underlying stool retention under-recognized until specifically asked about.
Normal variation in infant stool pattern
In the first 3 months of life, stool frequency in exclusively breastfed infants normally decreases from as often as 6 times per day to about 2 to 3 times per day, with more day-to-day fluctuation than in formula-fed infants. Exclusively breastfed infants can also go several days between bowel movements. This is a normal variant, not constipation, as long as the eventual stool is soft and the infant shows no distress — it should not by itself prompt investigation or treatment.
Risk Factors
- A prior painful or hard bowel movement (including one caused by an anal fissure) that triggers the withholding cycle — the single most common precipitant.
- The toilet-training period.
- In infants: introduction of semi-solid/solid food, or a switch from breast milk to formula or whole milk.
- Low dietary fibre or fluid intake.
- Constipating medications, e.g., opioids, anticholinergic agents, iron-containing products.
- Insufficient physical activity.
- Family history of constipation.
- Male sex — both sexes are affected by constipation itself, but males are more likely to develop encopresis/overflow fecal incontinence.
- Psychosocial stressors — a new sibling, starting school, family stress, or a history of abuse or other adverse childhood events (also a risk factor for slower improvement and relapse — see Monitoring & Follow-Up).
- Attention-deficit hyperactivity disorder (ADHD) or a neurodevelopmental disability (also a risk factor for slower improvement and relapse).
Red Flags & Refer
The following features suggest an organic cause of constipation — most importantly Hirschsprung disease, a congenital condition in which the distal bowel lacks the nerve cells needed for normal peristalsis — and warrant investigation and referral rather than a presumptive trial of standard functional-constipation therapy:
- Constipation with onset in the first month of life.
- Delayed passage of meconium, beyond 48 hours of life.
- Ribbon-like stools.
- Rectal bleeding with blood mixed in the stool when no anal fissure is present to explain it.
- Failure to thrive or poor growth.
- Severe abdominal distension.
- Bilious (green) vomiting, suggesting bowel obstruction.
- Bloody diarrhea, which in this context suggests Hirschsprung-associated enterocolitis, a surgical emergency.
- Abnormal position of the anus, or a physical exam suggesting imperforate anus or anal stenosis.
- Decreased lower-extremity tone or reflexes.
- A tuft or patch of hair, or a deep dimple, over the lower spine/sacrum.
- A sacral dimple or a deviated gluteal cleft.
- On digital rectal examination: a tight, empty rectal vault with explosive release of stool and gas on withdrawal of the examining finger — a classic finding in Hirschsprung disease.
- Severe constipation that does not respond to an adequately dosed and adequately long trial of standard therapy.
Assessment & Diagnosis
History
- Onset — specifically whether it began in the first month of life.
- Frequency of bowel movements and stool size/diameter.
- Abdominal pain, and pain specifically with passage of stool.
- Posturing or withholding behaviours (see Recognize the Condition).
- Episodes of fecal incontinence in a child who already has toileting skills.
- In infants: whether stool pattern is consistent with the normal breastfed-infant variation described above.
- A full medication review for a constipating drug.
Physical examination
- Abdominal exam: fullness or a palpable fecal mass in the left lower quadrant is common and supportive of the diagnosis.
- Perianal and lower-back exam: an anal fissure is common and is often supported by blood on wiping and pain after defecation; also examine the sacrum/lower spine and anal position for the red-flag findings above.
- Digital rectal exam: confirms the presence of a fecal mass, but is not always necessary, since the Rome IV diagnostic criteria can be met on history alone. When performed, a tight, empty rectum with explosive stool on withdrawal is a red flag for Hirschsprung disease, not a routine functional-constipation finding.
Rome IV criteria — functional constipation in neonates and toddlers (up to 4 years of age)
2 or more of the following, present for at least 1 month:
| Criterion | |
|---|---|
| 2 or fewer defecations per week | |
| History of excessive stool retention | |
| History of painful or hard bowel movements | |
| History of large-diameter stools | |
| Presence of a large fecal mass in the rectum on examination |
In toilet-trained children, 2 further criteria also apply: at least 1 episode per week of fecal incontinence after the acquisition of toileting skills, and a history of large-diameter stools that may obstruct the toilet.[2]
Rome IV criteria — functional constipation in children and adolescents (developmental age at least 4 years)
2 or more of the following, occurring at least once per week for a minimum of 1 month, with insufficient criteria for a diagnosis of irritable bowel syndrome:
| Criterion | |
|---|---|
| 2 or fewer defecations in the toilet per week | |
| At least 1 episode of fecal incontinence per week | |
| History of excessive stool retention | |
| History of painful or hard bowel movements | |
| Presence of a large fecal mass in the rectum on examination | |
| History of large-diameter stools that can obstruct the toilet |
Rome IV criteria for functional constipation, child/adolescent.[3]
Imaging and laboratory testing
There is no standard laboratory or imaging workup for a child presenting with typical functional-constipation symptoms and no red flags — diagnosis is based on history and physical exam. Abdominal x-ray correlates poorly with symptoms, especially in mild-to-moderate cases, and over-reliance on it should be avoided; its role is limited to situations where the diagnosis is unclear and an adequate abdominal exam cannot be performed. When systemic disease is specifically suspected: thyroid-stimulating hormone (TSH) if other features of hypothyroidism are present, and tissue transglutaminase (celiac screen) — though this is not a first-line investigation and should not be ordered routinely.[1]
Differential diagnosis to keep in mind
- Hirschsprung disease — consider specifically when constipation presents in the first month of life; see Red Flags & Refer for the supporting exam findings.
- Spinal cord abnormalities — suggested by a deep sacral dimple, a hairy tuft over the spine, leg weakness, or weak deep tendon reflexes in the lower extremities.
- Anatomic abnormalities — imperforate anus or anal stenosis, which can present with ribbon stools or a tight anal canal on exam.
- Cystic fibrosis — consider when failure to thrive accompanies respiratory symptoms.
- Medications — opioids and anticholinergic agents in particular.
- Cow's milk protein allergy — routine screening is not warranted, but this can be considered as a contributing factor in refractory cases (see Non-Pharmacologic Treatment).
- Hypothyroidism and celiac disease — uncommon causes; consider when other supporting features are present rather than screening routinely.
- Infant dyschezia — a distinct Rome IV entity in infants under 9 months: screaming, straining, and turning red before passing a soft, normal stool, from a failure to coordinate increased intra-abdominal pressure with pelvic floor relaxation. It resolves on its own and is not treated as constipation.
- Irritable bowel syndrome with predominant constipation (IBS-C) — consider in older children and adolescents when abdominal pain is the dominant symptom or persists despite improved stool pattern; general constipation-treatment principles still apply, but psychosocial factors such as stress and anxiety often need to be addressed as well.
Treatment Targets
- Achieve regular, soft, pain-free bowel movements.
- Break the cycle of voluntary and involuntary stool withholding.
- Decrease rectal distension and re-establish normal rectal calibre.
- Re-establish normal rectal sensation and the urge to defecate.
- Fully evacuate retained/impacted stool (disimpaction) before starting maintenance-dose therapy — maintenance dosing on top of an unresolved impaction will not achieve control.
- Sustain maintenance therapy long enough — typically months — to prevent relapse, rather than stopping as soon as symptoms first improve.
Choose Initial Treatment
Two sequential treatment phases, not one
Phase 1 — Disimpaction (clean-out)
Evacuates existing retained/impacted stool using a markedly higher PEG 3350 dose than maintenance, given for a short, defined course.
Phase 2 — Maintenance
A much lower daily PEG 3350 dose, continued for months, that prevents the withholding cycle from restarting once the rectum has been decompressed.
Confirm functional constipation first
Screen for red-flag features and apply the age-appropriate Rome IV criteria before starting treatment. If any red flag is present, investigate for an organic cause (Hirschsprung disease in particular) rather than proceeding directly to standard laxative therapy.
Phase 1 — Disimpaction
1st line high-dose oral polyethylene glycol (PEG) 3350, 1 to 1.5 g/kg/day PO, given once daily or in divided doses, for 3 to 6 days. Oral high-dose PEG is as effective as a rectal enema for disimpaction, even with a confirmed fecal impaction, and is generally more convenient and less distressing for the child.[4]
Alternative — use when the oral route fails, is refused or not tolerated, or when severe impaction with vomiting precludes oral intake rectal disimpaction with a sodium phosphate enema, or a glycerin suppository for a milder presentation.
Bowel evacuation is not immediate — it typically takes 24 to 48 hours to occur once disimpaction therapy begins. This delay is expected and is not treatment failure.
Phase 2 — Maintenance
1st line, started as soon as disimpaction is confirmed complete PEG 3350, 0.2 to 0.8 g/kg/day PO once daily — a markedly lower dose than the disimpaction phase. Titrate within this range to produce a soft, "mushy" daily stool without leakage; this can be done by the family once the target is explained.
2nd line — use when PEG 3350 is unavailable or not tolerated lactulose. It is less effective than PEG 3350 for maintenance and causes more bloating and abdominal pain, so reserve it for when PEG genuinely cannot be used.
Add a stimulant laxative — use when there has been no bowel movement after 3 days of optimized osmotic maintenance therapy, or in refractory cases bisacodyl or senna as an adjunct. Concern about dependency or cramping with stimulant laxatives is a common but poorly evidence-supported worry — this should not prevent their use when indicated, particularly on an as-needed basis.
Do not rely on a prokinetic (e.g., prucalopride) or a secretagogue (e.g., linaclotide) — these have a negligible role in pediatric functional constipation and are not routine options.
Non-Pharmacologic Treatment
Family and patient education
Explain that constipation in children is common, that it is genuinely unpleasant for the child, and that the child may not fully sense the retained stool, the urge to defecate, or their own withholding behaviour — this is not wilful misbehaviour. The parents' attitude is central to resolving the problem, and it is important they understand the child is not to blame.
Diet and fluids
- Ensure adequate water/fluid intake for the child's age.
- Encourage a reasonably balanced diet including fruits and vegetables, with attention to fibre intake — a practical target is the child's age in years plus 5 g per day.[5]
- Consider osmotic fruit juices (pear, prune, or apple) for mild constipation, particularly in infants and young children — their natural sorbitol content has a mild osmotic laxative effect.
Toileting routine and behavioural counselling
- Establish a regular toilet routine: have the child sit on the toilet for no more than 5 minutes, about half an hour after a meal, to take advantage of the gastrocolic reflex — even if there is no detectable urge to go.
- Provide foot support with a low stool for a child who cannot reach the floor while sitting.
- Give positive reinforcement — many children respond well to a reward chart — for simply sitting on the toilet, whether or not a bowel movement results.
- Avoid reprimanding or punishing the child for withholding or for a soiling accident — this reliably worsens the underlying withholding cycle rather than improving it.
- Encourage the child's own body awareness and watch for withholding signs (see Recognize the Condition) so the family can intervene early with the toileting routine.
- Keep a symptom journal recording bowel movement frequency and consistency, ideally using a common tool such as the Bristol stool form scale, to track progress objectively rather than by memory alone.
Physical activity
Encourage the child to participate in daily physical activity, which supports normal bowel motility alongside the toileting routine.
Cow's milk protein — evidence does not support routine restriction
Do not routinely blame or restrict cow's milk for a child with typical functional constipation. A time-limited (2 to 4 week) empirical cow's milk protein elimination trial can be considered specifically for difficult-to-treat or refractory constipation, particularly in infants, where an underlying cow's milk protein allergy is suspected — but this should be a defined trial with a food challenge to confirm the diagnosis if symptoms improve, not an open-ended, unconfirmed dietary restriction.[6]
Rectal therapy — minimize where possible
In general, avoid rectal therapy as a routine measure, since it can increase a child's defensiveness and worsen withholding behaviour. Reserve glycerin suppositories and enemas for the specific situations described in Choose Initial Treatment, not as a default first step.
Special Populations
Pregnancy
Not applicable — this chapter addresses pediatric patients, not pregnant adults.
Breastfed infants
Constipation is uncommon in exclusively breastfed infants before the introduction of solids or a switch to formula. An exclusively breastfed infant with infrequent but soft, non-distressing stools does not need treatment — see Recognize the Condition for the normal stool-pattern variation in this group.
Infants under 1 year
Screening for organic causes is especially important in this age group, since red flags overlap heavily with Hirschsprung disease features — onset in the first month of life, delayed meconium passage, and failure to thrive all warrant investigation rather than presumptive functional-constipation treatment. Mineral oil is contraindicated under 1 year given aspiration risk. Stimulant laxative dosing is not established below the youngest studied age bands (bisacodyl under 3 years, senna under 2 years) and these agents are not first-line in infancy.
Neurodevelopmental disabilities, ADHD, and history of adverse childhood events
These are recognized risk factors for slower improvement and more frequent relapse, and often warrant closer follow-up and a longer anticipated maintenance course. A non-punitive, trauma-informed approach to the behavioural/toileting component is especially important in this group. Use extra caution with rectal products (mineral oil aspiration risk, enema/suppository-related behavioural defensiveness) in children with neurodevelopmental disabilities.
Renal impairment
Use sodium phosphate-containing enemas with caution, or avoid them, in renal impairment, given the risk of electrolyte imbalance from phosphate absorption.
Monitoring & Follow-Up
Track bowel movement frequency and stool consistency using a symptom journal and the Bristol stool form scale rather than relying on caregiver recall alone. Confirm disimpaction was genuinely completed — resolution of any palpable fecal mass, and a return to frequent, soft stooling — before assuming maintenance-dose therapy has failed; an incompletely disimpacted child will not respond to maintenance dosing. PEG 3350 and lactulose doses can safely be titrated up if stools remain hard or infrequent, or down if stools become watery — these agents have a wide margin of safety. Maintain full symptom control for at least 1 month before attempting to wean maintenance therapy. Treatment duration for chronic constipation is typically measured in months, and a fair number of setbacks or relapses should be expected — from a change in schedule, diet, school attendance, travel, fears or phobias, or no identifiable reason at all. A relapse is not a sign that the overall approach has failed; if it occurs, repeat the disimpaction phase before resuming maintenance dosing. At every follow-up, reinforce the non-punitive parental approach and reassess adherence to the toileting routine and the reward system, since most children with persistent constipation ultimately improve with sustained support and time and do not go on to have lifelong symptoms.[1]
Common Errors to Avoid
- Mistaking overflow fecal incontinence (leakage around a large retained fecal mass) for diarrhea and withholding laxative therapy — this worsens the underlying constipation.
- Starting maintenance-dose PEG 3350 without first completing an adequate disimpaction phase.
- Stopping maintenance therapy as soon as symptoms first resolve, rather than continuing for the recommended duration (at least 1 month of full symptom control before weaning) — a leading cause of relapse.
- Reprimanding or punishing a child for withholding behaviour or a soiling accident.
- Treating red-flag features (delayed meconium passage, ribbon stools, failure to thrive, and similar) as ordinary functional constipation without investigation.
- Over-relying on abdominal x-ray to make or confirm the diagnosis — correlation with symptoms is poor, especially in mild-to-moderate cases.
- Instituting a prolonged, unconfirmed cow's milk restriction rather than reserving this for a defined, time-limited trial with a confirmatory challenge in refractory cases.
- Using an adult-strength rectal product (adult glycerin suppository, adult sodium phosphate enema) in a child instead of the pediatric-strength formulation.
- Giving mineral oil to an infant under 1 year of age or to any child with an aspiration risk factor.
- Assuming a fixed, adult-style bowel-movement frequency applies to every infant — an exclusively breastfed infant with infrequent but soft, non-distressing stools does not need treatment.
Clinical Decision Algorithm
Drug Tables
How to use this table: doses are weight- and age-banded pediatric doses and require patient-specific confirmation. Select any drug name to open its complete Pharmasist Drug Database page.
Osmotic laxatives
Polyethylene glycol (PEG) 3350 is the primary agent for both the disimpaction and maintenance phases; lactulose is a second-line alternative when PEG is unavailable or not tolerated.
| Drug | Dosage | Adverse effects | Comments |
|---|---|---|---|
| Polyethylene glycol (PEG) 3350 | Disimpaction, under 1 year: 4-17 g PO daily for 3-6 days Disimpaction, 1 to 4 years: 8.5-25 g PO daily for 3-6 days Disimpaction, 5 to 10 years: 17-34 g PO daily for 3-6 days Disimpaction, over 10 years: 34-68 g PO daily for 3-6 days Maintenance, under 1 year: 4-8.5 g PO once daily Maintenance, 1 to 4 years: 8.5-13 g PO once daily Maintenance, 5 to 10 years: 8.5-17 g PO once daily Maintenance, over 10 years: 17-34 g PO once daily | Common: nausea, cramping, diarrhea. Rare: hives, skin rash. | For convenience, 1 capful of most commercially available products equals 17 g. Dissolve in 250 mL of water or juice per 17 g and stir until fully dissolved. Total daily dose may be given as divided doses. Maintenance doses may be titrated up or down to achieve a soft daily stool without leakage. |
| Lactulose | Disimpaction, under 1 year: 7.5-30 mL PO daily for 3-6 days Disimpaction, 1 to 4 years: 15-45 mL PO daily for 3-6 days Disimpaction, 5 to 10 years: 30-60 mL PO daily for 3-6 days Disimpaction, over 10 years: 45-90 mL PO daily for 3-6 days Maintenance, under 1 year: 5-15 mL PO once daily Maintenance, 1 to 4 years: 7.5-30 mL PO once daily Maintenance, 5 to 10 years: 15-45 mL PO once daily Maintenance, over 10 years: 30-60 mL PO once daily | Bloating, flatulence, cramps, diarrhea. | 1 g is approximately 1.5 mL. Total daily dose may be given as divided doses. Maintenance doses may be titrated to achieve clinical efficacy. Reserve for when PEG 3350 is unavailable or not tolerated — less effective and generally causes more bloating/abdominal pain than PEG 3350. |
| Glycerin suppository | Under 6 years: 1 infant suppository PR, once daily or as needed 6 years and older: 1 adult suppository PR, once daily or as needed | Rectal irritation. | Use the pediatric (infant) strength suppository, not the adult strength, under 6 years. Minimize routine rectal-therapy use — it can worsen a child's withholding behaviour. |
| Sodium phosphates enema | 2 to 4 years: 33 mL PR as a single dose 5 to 12 years: 66 mL PR as a single dose Over 12 years: 133 mL PR as a single dose | Electrolyte imbalance. | Dosing follows approximately 2.5 mL/kg PR, to a maximum of 133 mL. Use the pediatric-strength product, not the adult product, in children. Do not repeat within 24 hours. Use with caution, or avoid, in renal impairment given electrolyte-imbalance risk. |
Lubricant laxative
An alternative when PEG 3350 is not tolerated or available; used less often given lower effectiveness than PEG 3350 and a real aspiration risk.
| Drug | Dosage | Adverse effects | Comments |
|---|---|---|---|
| Mineral oil | Under 1 year: Not recommended 1 to 5 years: 1-3 mL/kg PO once daily, sitting upright 6 to 12 years: 5-15 mL PO once daily, sitting upright Over 12 years: 15-45 mL PO once daily, sitting upright | Anal leakage and perianal irritation; lipoid pneumonia if aspirated. | Do not use under 1 year of age or in any child with an aspiration risk factor (gastroesophageal reflux, neurodevelopmental abnormality, swallowing dysfunction). A flavoured gel formulation is available to improve palatability. |
Stimulant laxatives
Reserve as an adjunct for refractory cases or when there is no stool after 3 days of optimized osmotic maintenance therapy. Concern about dependency with long-term use is common but poorly supported by evidence, particularly with as-needed dosing.
| Drug | Dosage | Adverse effects | Comments |
|---|---|---|---|
| Bisacodyl | 3 to 10 years: 5 mg PO once daily Over 10 years: 5-10 mg PO once daily | Abdominal pain, cramps, cathartic colon with prolonged use. | Stimulates colonic peristalsis. Usually intended for short-term use, though longer-term use may be appropriate when genuinely needed. |
| Senna | 2 to 5 years: 2.5-5 mg PO once or twice daily 6 to 12 years: 7.5-10 mg/day PO Over 12 years: 15-20 mg/day PO | Abdominal pain, cramps, cathartic colon with prolonged use. | Stimulates colonic peristalsis. Usually intended for short-term use, though longer-term use may be appropriate when genuinely needed. |
Evidence note: Drug inventory, dosing, adverse effects, and comments reflect standard Canadian pediatric practice, cross-checked against the current ESPGHAN/NASPGHAN evidence-based recommendations.[1]
References
- Evaluation and Treatment of Functional Constipation in Infants and Children: Evidence-Based Recommendations from ESPGHAN and NASPGHAN — Journal of Pediatric Gastroenterology and Nutrition (Tabbers MM, DiLorenzo C, Berger MY, et al.). J Pediatr Gastroenterol Nutr 2014;58(2):258-274
- Childhood Functional Gastrointestinal Disorders: Neonate/Toddler — Gastroenterology (Benninga MA, Nurko S, Faure C, et al.). Gastroenterology 2016;150(6):1443-1455
- Childhood Functional Gastrointestinal Disorders: Child/Adolescent — Gastroenterology (Hyams JS, Di Lorenzo C, Saps M, et al.). Gastroenterology 2016;150(6):1456-1468
- Rectal Fecal Impaction Treatment in Childhood Constipation: Enemas Versus High Doses Oral PEG — Pediatrics (Bekkali NLH, van den Berg MM, Dijkgraaf MGW, et al.). Pediatrics 2009;124(6):e1108-e1115
- A New Recommendation for Dietary Fiber in Childhood — Pediatrics (Williams CL, Bollella M, Wynder EL). Pediatrics 1995;96(5):985-988
- Cows' Milk Allergy-Associated Constipation: When to Look for It? A Narrative Review — Nutrients (Simeone D, Miele E, Boccia G, et al.). Nutrients 2022;14(6):1317
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.